| Normal (n = 25) | ERSD(n = 66) |
---|---|---|
Age(Y) | 51.21 ± 6.06 | 55.10 ± 15.83 |
Male (n, %) | 9 (36.00%) | 25 (37.87%) |
Weight (kg) | 57.83 ± 8.45 | 58.01 ± 11.29 |
Height (cm) | 160.70 ± 6.39 | 158.93 ± 8.47 |
BMI (kg/m2) | 24.02 ± 2.53 | 22.75 ± 3.61 |
BSA(m2) | 1.52 ± 0.13 | 1.56 ± 0.178 |
Systolic blood pressure (mmHg) | 117.25 ± 13.48 | 141.45 ± 23.45 |
Diastolic blood pressure (mmHg) | 70.69 ± 19.17 | 86.84 ± 16.05 |
HR (beats/min) | 72.35 ± 21.66 | 81.81 ± 14.38 |
During of CKD | – | 3 month-20 year |
During of dialysis | – | 3 month-11 year |
Occurrence of HF (n, %) | – | 25 (37.87%) |
Causes of ESRD | ||
 Polycystic kidney disease (n, %) | – | 16 (24.24%) |
 Primary glomerular nephropathy (n, %) | – | 35 (53.03%) |
 Vasculitis (n, %) | – | 3 (4.54%) |
 Genitourinary tuberculosis (n, %) | – | 2 (3.03%) |
 Ureteral tumor (n, %) | – | 1 (1.51%) |
 Primary hypertension | – | 9 (13.64%) |
The biochemical measurements | ||
 eGFR (ml/min/1.732 m2) (normal range 80-120 ml/min/1.72 m2) | – | 6.35 ± 2.77 |
 Urea (mmol/l) (normal range 3.30–8.22)* | – | 909.00 (651.00–1052.25) |
 Uric acid (umol/l) (normal range 240.0–490.0) | – | 432.63 ± 147.28 |
 Creatinine (umol/l) (normal range53.0–140.0) | – | 824.07 ± 290.44 |
 Hct (L/L) (normal range0.40–0.50) | – | 0.34 ± 0.06 |
 PTH (pmol/l) (normal range 1.6–6.9) * | – | 33.55 (21.62, 73.245) |
 Hb(g/l) (male 120–160; female110–150) | – | 102.15 ± 26.72 |
Blood pressure Medications | ||
 Angiotensin converting enzyme inhibitor or angiotensin receptor blocker diuretic | – | 25 (37.88%) |
 Calcium channel blocker | – | 38 (57.57%) |
 ɑ blocker | – | 15 (46.88%) |
 β blocker | – | 10 (15.16%) |